Number of Shares
232,758.00
Current Holdings Value*
$3.35 Mil
% of Portfolio
0.68%
Total Estimate Gain
$2.91 Mil
% of Total Estimate Gain
31.85%

SILVERARC CAPITAL MANAGEMENT, LLC's Centessa Pharmaceuticals PLC Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 232,758.00 shares of Centessa Pharmaceuticals PLC(CNTA), totaling $3.35 Mil. This investment constitutes 0.68% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0.17% of the outstanding Centessa Pharmaceuticals PLC(CNTA) stock.

The initial trade took place in 2024Q3. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 1 purchases of CNTA, at an average price of $12.25, for a total of 744,592.00 shares. In addition, there have been 2 sales at an average price of $16.42 for 511,834.00 shares. Based on historical transaction data and CNTA's current price of $15.57, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his CNTA holdings is $2.91 Mil, reflecting a 31.85% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC CNTA ($15.57) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC CNTA ($15.57) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1